Percheron Therapeutics Ltd ATHJF
AUD0.04
Last Updated: Nov 05, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
ATHJF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Percheron Therapeutics Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Percheron Therapeutics Ltd. Stock Analysis ATHJF
United States Health Care Nano Cap Percheron Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-12-20. The firm is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The firm is conducting a Phase II clinical trial of ATL1102 in DMD patients.
Percheron Therapeutics Ltd (ATHJF) Chart
Financial Metrics & Statements of Percheron Therapeutics Ltd (ATHJF)
FAQ's for Percheron Therapeutics Ltd (ATHJF)
- As of August 2026, Percheron Therapeutics Ltd ATHJF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Percheron Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Percheron Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Percheron Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Percheron Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Percheron Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Percheron Therapeutics Ltd (ATHJF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
